Exelixis Inc (EXEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EXEL | GH | BMRN | ||
| Company | Exelixis Inc | Guardant Health Inc | Biomarin Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 41.82 | 85.01 | 54.42 | ||
| High | 42.24 | 87.41 | 55.00 | ||
| Low | 41.57 | 84.60 | 53.94 | ||
| Latest | 41.95 | 86.20 | 54.79 | ||
| Change | +0.42 | +1.59 | +0.65 | ||
| % Change | +1.01% | +1.88% | +1.20% | ||
| Volume | 2,103,865 | 2,072,232 | 999,316 | ||
| 20-Day Average Volume | 2,831,443 | 1,769,692 | 1,993,501 | ||
| Previous Close | 41.53 | 84.61 | 54.14 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 41.57 | 88.04 | 57.37 | ||
| 20-Day Raw Stochastic | 53.35% | 27.63% | 16.66% | ||
| 20-Day Relative Strength | 48.29 | 41.25 | 40.89 | ||
| Weighted Alpha | +12.06 | +63.22 | -9.23 | ||
| Today's Opinion | 8% Buy | 24% Sell | 8% Sell | ||
| Previous Opinion | 40% Sell | 24% Sell | 8% Sell | ||
| Last Month's Opinion | 80% Buy | 24% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.30% since 03/23/26 | +1.46% since 03/23/26 | +0.02% since 03/23/26 | ||
| Low | 40.84 on 03/24/26 | 82.39 on 03/24/26 | 53.35 on 03/24/26 | ||
| High | 43.48 on 03/25/26 | 89.26 on 03/25/26 | 56.06 on 03/26/26 | ||
| 1-Month | |||||
| %Chg | -4.79% since 02/27/26 | -8.20% since 02/27/26 | -11.24% since 02/27/26 | ||
| Low | 39.71 on 03/02/26 | 82.26 on 03/12/26 | 53.35 on 03/24/26 | ||
| High | 43.48 on 03/25/26 | 96.52 on 03/05/26 | 61.97 on 03/10/26 | ||
| 3-Month | |||||
| %Chg | -9.28% since 12/26/25 | -16.29% since 12/26/25 | -8.61% since 12/26/25 | ||
| Low | 39.71 on 03/02/26 | 82.26 on 03/12/26 | 53.35 on 03/24/26 | ||
| High | 46.31 on 01/07/26 | 120.74 on 01/22/26 | 66.28 on 02/24/26 | ||
| 6-Month | |||||
| %Chg | +7.45% since 09/26/25 | +43.59% since 09/26/25 | +1.75% since 09/26/25 | ||
| Low | 33.76 on 10/20/25 | 59.63 on 09/29/25 | 50.76 on 11/07/25 | ||
| High | 47.24 on 12/23/25 | 120.74 on 01/22/26 | 66.28 on 02/24/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,785,715 | 11,098,292 | 10,412,366 | ||
| Shares Outstanding, K | 259,709 | 131,170 | 192,323 | ||
| Annual Sales | 2,320,130,000 | 982,020,000 | 3,221,250,000 | ||
| Annual Net Income | 782,570,000 | -416,280,000 | 348,900,000 | ||
| Last Quarter Sales | 598,660,000 | 281,270,000 | 874,560,000 | ||
| Last Quarter Net Income | 244,530,000 | -128,490,000 | -46,570,000 | ||
| 60-Month Beta | 0.41 | 1.67 | 0.25 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.94 on 02/10/26 | -0.50 on 02/19/26 | 0.46 on 02/23/26 | ||
| Latest Earnings Date | 05/12/26 | 04/29/26 | 05/07/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 15.52 | 0.00 | 22.86 | ||